Literature DB >> 15579229

Growth characteristics of renal cortical tumors in patients managed by watchful waiting.

Richard D Sowery1, D Robert Siemens.   

Abstract

OBJECTIVE: To characterize tumor growth of patients managed conservatively for renal cell carcinoma.
METHODS: Patients electing conservative management of radiographically determined renal cell carcinomas were referred to a surveillance database. Exclusion criteria consisted of locally advanced disease (>T2) and those with metastatic disease. Clinical follow-up included renal imaging with ultrasound or computed tomography at least every 6 months.
RESULTS: Twenty-two patients were originally managed conservatively, two of whom subsequently underwent nephrectomy because of rapid tumor growth. Mean follow-up was 26 months. Mean tumor volume and diameter at presentation was 62.4 cc and 4.08 cm respectively. Overall tumor growth was 24 cc/year by volume or .86 cm/year diameter.
CONCLUSIONS: Given the stage migration of incidentally detected renal masses, the natural history of these tumors remains incomplete. Overall tumor growth in selected populations appear to be slow even in those diagnosed with larger masses. These data may be useful in counseling patients and directing further trials on conservative therapy for renal cell carcinoma.

Entities:  

Mesh:

Year:  2004        PMID: 15579229

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  17 in total

1.  Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Rebecca I Hartman; Mukesh G Harisinghani; Adam S Feldman; Peter R Mueller; G Scott Gazelle
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

Review 2.  Image-guided radiofrequency ablation of renal cell carcinoma.

Authors:  Andreas Boss; Stephan Clasen; Markus Kuczyk; Fritz Schick; Philippe L Pereira
Journal:  Eur Radiol       Date:  2006-10-05       Impact factor: 5.315

Review 3.  Imaging renal cell carcinoma with ultrasonography, CT and MRI.

Authors:  Michael J Leveridge; Peter J Bostrom; George Koulouris; Antonio Finelli; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-05-18       Impact factor: 14.432

Review 4.  Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis.

Authors:  Marc C Smaldone; Alexander Kutikov; Brian L Egleston; Daniel J Canter; Rosalia Viterbo; David Y T Chen; Michael A Jewett; Richard E Greenberg; Robert G Uzzo
Journal:  Cancer       Date:  2011-07-15       Impact factor: 6.860

5.  Increasing detection and increasing incidence in thyroid cancer.

Authors:  Stephen F Hall; Hugh Walker; Robert Siemens; Amy Schneeberg
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

6.  Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance.

Authors:  Paul L Crispen; Rosalia Viterbo; Stephen A Boorjian; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  Cancer       Date:  2009-07-01       Impact factor: 6.860

7.  Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival?

Authors:  Andrew A Stec; Benjamin J Coons; Sam S Chang; Michael S Cookson; S Duke Herrell; Joseph A Smith; Peter E Clark
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

8.  Progression to metastatic disease from a small renal cell carcinoma prospectively followed with an active surveillance protocol.

Authors:  Jaime A Wong; Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

Review 9.  Active surveillance of small renal masses.

Authors:  Marc C Smaldone; Anthony T Corcoran; Robert G Uzzo
Journal:  Nat Rev Urol       Date:  2013-04-09       Impact factor: 14.432

10.  Watchful waiting in the treatment of the small renal mass.

Authors:  K Clint Cary; Chandru P Sundaram
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.